Shortage of certain supplies needed for creating testing kits can worsen the pandemic situation.
This piece states the US Food and Drug Administration is using Twitter to identify potential lacunas in the supply chain of coronavirus tests. As per Politico, mandate medical device manufacturers cannot report supply chain shortages due to a decade-old law.
FDA has turned to Twitter urging medical device manufacturers to make their medical device inventory and production schedule public. The authority was specifically looking for information on the swab, transport media, extraction reagents, controls, PCR reagents, test kits and instruments.
Manufacturers should also provide a hotline number to address questions regarding the availability of reagents and other supplies needed for COVID-19 testing to maximise efficient testing. The article suggests the FDA would rely on the social media platform until the legislation “gets back on track”.
[1 minute read]